TScan Therapeutics TCRX
NASDAQ TCRX
$0.14 -0.01 (-6.67%)
At close: Nov 19, 2026 · 4:00 PM EST

TScan Therapeutics (TCRX) Interest & Investment Income (2020 - 2026)

Updated

TScan Therapeutics' Interest & Investment Income was $721,000 in Q3 2026, down 64.7% from $2.04 million a year earlier and down 13.4% from the prior quarter.

Analysis

TScan Therapeutics (TCRX) Interest & Investment Income (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, TScan Therapeutics' Interest & Investment Income was $4.3 million through Sep 30, 2026, down 57.1% year-over-year; for FY2025, it was $8.82 million, down 26.9% from FY2024.

  • Interest & Investment Income shows a five-year compound annual growth rate of 142.1% (FY2020 to FY2025).
  • In earlier years, Interest & Investment Income was $12.07 million in FY2024 (+50.8%), $8 million in FY2023 (+402.8%), $1.59 million in FY2022 and $16,000 in FY2021 (-84.9%).
  • The Q3 2026 figure marks the lowest quarterly Interest & Investment Income since Q3 2022.
  • Compared with a year earlier, Interest & Investment Income has declined for six straight quarters, with an average decline of 33.9% over the last eight quarters.
  • The best year-over-year quarter for Interest & Investment Income over five years was Q2 2023 (growth of 929.5%); the worst was Q2 2026 (a decline of 65.1%).
  • Per Business Quant data, TCRX's Interest & Investment Income in the three quarters before Q3 2026 was $833,000 (Q2 2026), $1.16 million (Q1 2026) and $1.58 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn -
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 186.00 Mn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn -
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn -
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn -
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn -
9 Gsk 193.54 Bn 176.38 Bn - -
10 TScan Therapeutics 18.87 Mn -434.83 Mn - 721,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 721,000.00
Jun 30, 2026 833,000.00
Mar 31, 2026 1.16 Mn
Dec 31, 2025 1.58 Mn
Sep 30, 2025 2.04 Mn
Jun 30, 2025 2.39 Mn
Mar 31, 2025 2.80 Mn
Dec 31, 2024 2.78 Mn
Sep 30, 2024 3.69 Mn
Jun 30, 2024 3.41 Mn
Mar 31, 2024 2.19 Mn
Dec 31, 2023 2.60 Mn
Sep 30, 2023 2.73 Mn
Jun 30, 2023 1.53 Mn
Mar 31, 2023 1.14 Mn
Dec 31, 2022 901,000.00
Sep 30, 2022 534,000.00
Jun 30, 2022 149,000.00
Mar 31, 2022 7,000.00
Dec 31, 2021 2,000.00
API Access

TScan Therapeutics Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=TCRX&period=max&api_key=YOUR_API_KEY